Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | HTR2B | P41595 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL300776 | 1.00 | ALDH1A1 (0.59) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL5056709 | 0.91 | ALDH1A1 (0.52) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL23748684 | 0.87 | ALDH1A1 (0.44) | ALDH1A1KMT2APTK2BKDM4ENPC1 | |
| SCHEMBL28620825 | 0.87 | ALDH1A1 (0.44) | ALDH1A1KMT2APTK2BKDM4ENPC1 | |
| SCHEMBL25194130 | 0.87 | KDM4E (0.51) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL25265029 | 0.87 | KDM4E (0.51) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL31109156 | 0.82 | ALDH1A1 (0.56) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL2887745 | 0.81 | KMT2A (0.59) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL7710661 | 0.81 | KMT2A (0.63) | ALDH1A1KMT2APTK2BKDM4ENPSR1 | |
| SCHEMBL6925754 | 0.81 | KMT2A (0.59) | ALDH1A1KMT2APTK2BKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2662434-B2 | Use of specific compounds for enhancing odours | SYMRISE AG (DE) | 2023-08-16 | — | — | EP | claimed |
| US-11179310-B2 | Fragrance compositions and products with mood enhancing effects | SYMRISE AG (DE) | 2021-11-23 | — | — | US | claimed |
| EP-3621577-B1 | NOVEL FRAGRANCE COMPOSITIONS AND PRODUCTS WITH MOOD ENHANCING EFFECTS | SYMRISE AG (DE) | 2021-06-30 | — | — | EP | claimed |
| CN-104837973-B | Fragrance materials | 宝洁公司 | 2020-04-21 | — | — | CN | claimed |
| EP-2662434-B1 | Use of specific compounds for enhancing odours | SYMRISE AG (DE) | 2018-03-21 | — | — | EP | claimed |
| EP-1448757-B2 | PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS | PROCTER & GAMBLE (US) | 2015-04-08 | — | — | EP | claimed |
| EP-1448757-B1 | PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS | PROCTER & GAMBLE (US) | 2012-05-30 | — | — | EP | claimed |
| EP-1848702-A2 | PRO-FRAGRANCE AND PRO-FLAVORANT COMPOSITIONS | Flexitral, Inc. (US) | 2007-10-31 | — | — | EP | claimed |
| US-20060205632-A1 | Pro-fragrance and pro-flavorant compositions | FLEXITRAL, INC. | 2006-09-14 | — | — | US | claimed |
| WO-2006085048-A2 | PRO-FRAGRANCE AND PRO-FLAVORANT COMPOSITIONS | FLEXITRAL, INC. (US) | 2006-08-17 | — | — | WO | claimed |
| US-6858575-B2 | Pro-perfume compositions and substrate-treating products and methods using them | PROCTER & GAMBLE COMPANY (US) | 2005-02-22 | — | — | US | claimed |
| US-20030171250-A1 | Pro-perfume compositions and substrate-treating products and methods using them | THE PROCTER & GAMBLE COMPANY | 2003-09-11 | — | — | US | claimed |
| EP-1314777-A1 | Pro-perfume compositions used in cleaning or fabric treatment products | THE PROCTER & GAMBLE COMPANY (US) | 2003-05-28 | — | — | EP | claimed |
| EP-3684898-B1 | METHOD FOR PRODUCING AN ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| EP-3438137-B1 | MODIFIED HYDROCARBON RESIN AND HOT-MELT ADHESIVE COMPOSITION | ZEON CORP (JP) | 2024-01-31 | — | — | EP | disclosed |
| EP-3604356-B1 | MODIFIED HYDROCARBON RESIN | ZEON CORP (JP) | 2023-08-02 | — | — | EP | disclosed |
| US-5837671-A | ETHYL OCTADIENOATE FOR TASTE AND ODOR | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 1998-11-17 | — | — | US | disclosed |
| EP-0761808-A2 | Use of substituted lactones as perfuming agent | HAARMANN & REIMER GMBH (DE) | 1997-03-12 | — | — | EP | disclosed |
| EP-0094722-B1 | 10-ISOPROPYL-2,7-DIMETHYL-1-OXASPIRO(4.5)DECA-3,6-DIENE, ITS USE IN PERFUMES AND AROMAS | NAARDEN INTERNATIONAL N.V. (NL) | 1986-02-26 | — | — | EP | disclosed |
| EP-0094722-A1 | 10-Isopropyl-2,7-dimethyl-1-oxaspiro(4.5)deca-3,6-diene, its use in perfumes and aromas | NAARDEN INTERNATIONAL N.V. (NL) | 1983-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171250-A1 | Pro-perfume compositions and substrate-treating products and methods using them | FASN, ALOX5, PAM | ALDH1A1 333/4885KMT2A 2935/4885PTK2B 3705/4885 |
| US-20060205632-A1 | Pro-fragrance and pro-flavorant compositions | TAS2R10, TAS2R9, OR10J3 | ALDH1A1 1201/4885KMT2A 3814/4885PTK2B 4409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.